oral ghk-cu peptide supplement Theramid Copper Oral Liposomal Copper GHK –

Though the gene encoding DSIP has not been identified and its receptor remains unknown, emerging studies indicate that its activity may be mediated through NMDA receptors in the brain and 1-adrenergic pathways in peripheral tissues

However, the tirzepatide combination has the advantage of using an FDA-approved base compound with extensive safety data

It is not evaluated or approved by the FDA, EMA, or any other regulatory authority for human or animal consumption, diagnostics, or therapeutic purposes

The formulation is enhanced with vitamins, antioxidants, and natural extracts

These medications should be used in combination with diet and exercise